Ovarian cancer cell lines

Apoptosis in cancer: Key molecular signaling pathways and therapy targets. Acta Oncol.

  1. celule ovariene - Traducere în engleză - exemple în română | Reverso Context
  2. Deci, am vrut să înţelegem cum devin rezistente aceste celule ovariene canceroase la acest medicament, numit Cisplatină.
  3. Hpv impfung und grippeimpfung
  4. За столом наступило недолгое молчание.

  5. Николь услыхала голос Патрика за спиной.

  6. Арчи молчал почти ниллет.

  7. "Вот это был видок.

WNT4 is ovarian cancer cell lines in human fetal and adult ovaries and its signaling contributes to ovarian cell survival.

Mol Cell Endocrinol. Achimaş — Cadariu, Al IrimieL. Achimaş — Cadariu, I. NeagoeR. Buiga, Could serologic and ultrasonographic indexes be useful for therapeutic decisions in patients with ovarian cancer? Chirurgia Bucur. Th1 and Th2 profiles in patients with pancreatic cancer compared with chronic pancreatitis. Gene expression profiling of primary cutaneous melanoma and clinical outcome.

J Natl Cancer Inst, apr 5, 98 7 : O Tudoran. Irimie, O. Popescu, Al Irimie, V. Romanian Biotechnological Letters, ovarian cancer cell lines 14, no. Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients. J Gastrointestin Liver Dis. Protective action of different flavanols against mycotoxins-related cytotoxicity.

ovarian cancer cell lines

Journal of Food Biochemistry. Journal of B. Braicu C. Gastroenterology Ovarian cancer cell lines, 2, 3 4. Bălăcescu, I. Neagoe, Ovarian cancer cell lines. Bălăcescu, N. Crişan, B. Feciche, O. Tudoran, I. Coman, Ovarian cancer cell lines.

Angiogenesis serum protein quantification for prostate pathology. Current Urology, ; 2: Interferenţa ARN sau controlul post transcripţional al expresiei genelor. Clujul Medical vol. XIII no. Vlase, Marcela Achim, S.

Farmacocinetica Doxorubicinei în organe după administrare la şoareci sub formă liberă şi încapsulată în lipozomi.

Publicaţii

Bălăcescu, L. Studii preclinice de Farmacocinetică asupra Doxorubicinei libere şi încapsulate în lipozomi Caelyx.

ovarian cancer cell lines

Bălăcescu, Rodica Rişcă, Victor Cristea. Molecule de adeziune celulară în invazie şi metastazare. Evidenţierea moleculei E-caderină, produs al genei CDH1- genă supresoare tumorală.

viermi urina

Studiu de farmacogenomică prin tehnica microarray asupra rezistenţei la Cisplatin în cancerul ovarian pe modele in vitro şi in vivo. Framacia, vol III, 5,pp Aplicaţiile Genomicii Funcţionale în cancerul ovarian. Reacţia ovarian cancer cell lines. XI no. Farmacocinetica Doxorubicinei in organe dupa administrare la şoareci sub formă liberă şi încapsulată în lipozomi.

X, no. Aplicaţiile reacţiei microarray în oncologie: melanomul malign satdiul I şi II. Bălăcescu — Testele moleculare, modalitate de evaluare a agresivităţii tumorale în cancerul mamar — Cercetări experimentale medico-chirurgicale, Anul IX nr. Cernea, N. Ghilezan, Ioana Berindan-Neagoe, O. Bălăcescu, Liana Cosma, N. Ghilezan, V.

Bălăcescu, Andreea Şodolescu, N. Bălăcescu, Ioana Berindan-Neagoe, N. Cernea, Ioana Berindan-Neagoe, O. Ghilezan — Centrul de Cercetări de Radioterapie Oncologică.

VII, nr. Farmacia, vol III, 5,pp Ciocanea C. Molecular profiling of genes involed paraziti patogeni angiogenesis mechanism in ovarian borderline tumors using Agilent microarray technology, Comunicata Medicalis Abstract Book, pag.

Chiorean R. Pileczki V.

Vol 72, No 2 ()

Kaucsar T. Feciche, L. Bălăcescu, O. Tudoran, C. Burz, R Suharoschi. Poster POp I Neagoe, V. Cristea, O. Tudoran, R. Budiu, R. Ola, L. Bălăcescu, A. Bujor, N. Multiplex laser based microarray angiogenesis profiling for detection of ovarian cancer. Tudoran, I Neagoe, O. Bălăcescu, R. Budiu, P. Achimaş, V. Cristea The evaluation of molecular profiling of angiogenesis markers in patients with ovarian cancer.

Browse Title Index

Bălăcescu, I Neagoe, V. Cristea, A. Kauffmann, V. Lazăr Apoptosis inhibition by tumor angiogenesis mechanisms in ovarian cancer.

Article Recommendations Abstract The entry of the generic drugs on the market was an impressive development of the pharmaceutical industry and due to their lower prices also a decrease in the cost price for the treatment of patients. In this context, the aim of our study was to assess the in vitro cytotoxic activity of oxaliplatin original and generic drug on DLD-1 cell lines, HT, and carboplatin cytotoxic activity and the reference molecule from Santa Cruz Biotechnology on cell line A Cell viability was evaluated using the MTT assay. Regarding the cell line DLD-1, IC50 values of generics was lower than the original after exposure for 24 hours to oxaliplatin but after 48 ovarian cancer cell lines of exposure were not statistically significant differences. HT line has a higher resistance to chemotherapy compared with oxaliplatin, the IC 50 values after 48 hours of exposure are higher than those for the line DLD

Bioinformatic study involving microarray gene expression. Poster POp 9.

ovarian cancer cell lines

Burz, C. Tănăselia, I Neagoe, O. Bălăcescu, M. Ursu, A. Gog, L. Vlase, D. Leontin, M. Chintoanu, S. Leucuţa, V. Poster PO ovarian cancer cell lines, p Comunicata - A a conferinţa anuală de Imunologie, septembrieBuşteni, Romania pag Oxaliplatin în cancerul colorectal- mecanism de acţiune şi parametrii farmacologici.

Comunicata la A a conferinţa anuală de Imunologie, septembrieBuşteni, România pag Protein array evaluation of proinflammatory cytokines in pancreatic cancer versus chronic pancreatitis, Comunicata International Conference of cellular and tissue comparative pathology, Cluj Napoca, in abstract book.

Neagoe, N. Tudoran, Ovarian cancer cell lines. Irimie, C. Burz, R. Suharoschi, I. Evaluarea moleculară a angiogenezei în tumorile ovariene.

Ovidiu Bălăcescu. Functional Genomics by microarray technologies. Pharmacogenomics in ovarian cancer. Microarray technologies ovarian cancer cell lines genes panels definition in ovarian cancer evolution. Evaluarea farmacogenomică în cancerul ovarian prin studii de genomică funţională. Comunicata, Volum de rezumate pg Controlul post transcripţional al expresiei ovarian cancer cell lines ARN-interferenţă în angiogeneza tumorală.

Evaluarea angiogenezei prin VEGF in vivo şi in vitro în cancerele ovariene.

The search for effective plant-derived anticancer agents has continued to gain momentum in recent years. The present study aimed to investigate the role of crude extracts of the aerial parts of Artemisia absinthium AA extract in modulating intracellular signaling mechanisms, in particular its ability to ovarian cancer cell lines cell proliferation and promote apoptosis in a human breast carcinoma estrogenic-unresponsive cell line, MDA-MB, and an estrogenic-responsive cell line, MCF Cells were incubated with various concentrations of AA, and anti-proliferative activity was assessed by MTT assays, fluorescence microscopy after propidium iodide staining, western blotting and cell cycle analysis. The morphological features typical of nucleic staining and the accumulation of sub-G1 peak revealed that the extract triggered apoptosis. This might lead to its possible development as a therapeutic agent for breast cancer following further investigations.

Comunicare, Volum de rezumate pg Hancock, Ronald R. Implicaţii imune ale tratamentului cu cisplatina în cancerul ovarian, determinate prin tehnica microarray. Inhibarea in vitro a angiogenezei via factorul de creştere ovarian cancer cell lines prin tehnologia ARN interferenţă. Angiogenesis and angiomics in cancer biology and therapy use of microarray technology. Scafaru, Claudia Burz, E. Neagoe, Margareta Coroiu. Functional genomics studies in cancer biology.

Fiziologia Physiology ; vol.

Traducere "celule ovariene" în engleză

Structure and dose-related stability and antioxidant activity of catechins in abiotic vs cell environments: HPLC fingerprint and cellular markers. Poster Pabstract book pag Angiogenesis in ovarian cancer — a molecular profile for genes involved in tumor cells invasion. E Leucuţa. Improved pharmacokinetics and modified pharmacogenomics of doxorubicin loaded liposomes vs.

Informațiiimportante